Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1.Saito, T., Bokhove, M., Croci, R., Zamora-Caballero, S., Han, L., Letarte, M., de Sanctis, D., Jovine, L.
(2017) Cell Rep 19: 1917-1928
- PubMed: 28564608
- DOI: 10.1016/j.celrep.2017.05.011
- Primary Citation of Related Structures:
- PubMed Abstract:
- BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker, M.,van Dinther, M.,Liu, Z.,van Bezooijen, R.L.,Zhao, Q.,Pukac, L.,Lowik, C.W.,ten Dijke, P.
(2007) J. Cell. Sci. 120: 964
- Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells.
Gougos, A.,Letarte, M.
(1990) J. Biol. Chem. 265: 8361
- Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies.
Nolan-Stevaux, O.,Zhong, W.,Culp, S.,Shaffer, K.,Hoover, J.,Wickramasinghe, D.,Ruefli-Brasse, A.
(2012) PLoS ONE 7: e50920
- Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth.
Castonguay, R.,Werner, E.D.,Matthews, R.G.,Presman, E.,Mulivor, A.W.,Solban, N.,Sako, D.,Pearsall, R.S.,Underwood, K.W.,Seehra, J.,Kumar, R.,Grinberg, A.V.
(2011) J. Biol. Chem. 286: 30034
- Structural and functional insights into endoglin ligand recognition and binding.
Alt, A.,Miguel-Romero, L.,Donderis, J.,Aristorena, M.,Blanco, F.J.,Round, A.,Rubio, V.,Bernabeu, C.,Marina, A.
(2012) PLoS ONE 7: e29948
Endoglin (ENG)/CD105 is an essential endothelial cell co-receptor of the transforming growth factor β (TGF-β) superfamily, mutated in hereditary hemorrhagic telangiectasia type 1 (HHT1) and involved in tumor angiogenesis and preeclampsia. Here, we pr ...
Endoglin (ENG)/CD105 is an essential endothelial cell co-receptor of the transforming growth factor β (TGF-β) superfamily, mutated in hereditary hemorrhagic telangiectasia type 1 (HHT1) and involved in tumor angiogenesis and preeclampsia. Here, we present crystal structures of the ectodomain of human ENG and its complex with the ligand bone morphogenetic protein 9 (BMP9). BMP9 interacts with a hydrophobic surface of the N-terminal orphan domain of ENG, which adopts a new duplicated fold generated by circular permutation. The interface involves residues mutated in HHT1 and overlaps with the epitope of tumor-suppressing anti-ENG monoclonal TRC105. The structure of the C-terminal zona pellucida module suggests how two copies of ENG embrace homodimeric BMP9, whose binding is compatible with ligand recognition by type I but not type II receptors. These findings shed light on the molecular basis of the BMP signaling cascade, with implications for future therapeutic interventions in this fundamental pathway.
Department of Biosciences and Nutrition and Center for Innovative Medicine, Karolinska Institutet, Huddinge 14183, Sweden.,Department of Biosciences and Nutrition and Center for Innovative Medicine, Karolinska Institutet, Huddinge 14183, Sweden. Electronic address: firstname.lastname@example.org.,ESRF-The European Synchrotron, Grenoble 38000, France.,Molecular Medicine, Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, University of Toronto, Toronto, ON M5G 0A4, Canada; Department of Immunology, University of Toronto, Toronto, ON M5G 0A4, Canada.